Trial
NCT04361851
Study of Dara-Pembro for Multiple Myeloma Patients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
Merck Sharp & Dohme LLC
Condition
Multiple Myeloma
Intervention
Pembrolizumab
Why stopped
Low enrollment due to competing studies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-26